Association between elevated C-reactive protein and mortality, healthcare resource utilization and costs in patients with atherosclerotic cardiovascular disease and/or chronic kidney disease
European Heart Journal Open · 03.11.2026 · 6 (6)
DOI: 10.1093/ehjopen/oeag177 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 14.10.2026. Verfasst von Kausik K Ray und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Primary Care and Public Health, School of Public Health, Imperial College London, 320 Reynolds Building, Charing Cross Campus, London, …. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk A/S.
Abstract (Originalsprache)
Aims
Atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD) impact health and healthcare systems. Inflammation is a potential modifiable risk factor for both conditions. The case for evaluating the modification of inflammation in these conditions could be strengthened by evidence that systemic inflammation [C-reactive protein ≥2 mg/L] was associated with a considerable health burden. Methods and results A retrospective observational cohort study of 179 261 individuals in mutually exclusive cohorts (ASCVD only, CKD stages 3–4 only, ASCVD + CKD stages 3–4) and a reference cohort (no ASCVD or CKD) with ≥1 C-reactive protein measurement after diagnosis. Outcomes included all-cause mortality, healthcare resource utilization (HCRU), and direct healthcare costs. Chronic kidney disease stages 3–4, ASCVD only, and ASCVD + CKD stages 3–4 cohorts compared with the reference cohort were associated with increasing all-cause mortality (death/100 000 person-years) of 1637, 2090, 5163, and 946, respectively. HCRU events per person per year (PPPY) and mean direct costs PPPY were 20.4, 21.4, 34.2, and 8.2 and £2593, £3098, £6810, and £1144, respectively. Within cohorts, all-cause mortality increased progressively across C-reactive protein quartiles (Q) and was highest in Q4 among the ASCVD + CKD stages 3–4 cohort, with a hazard ratio (Q4 vs. Q1) of 2.75 in this cohort compared with 1.22 in the reference cohort.
Conclusion
While the clinical impact of targeting inflammation is being evaluated in ongoing trials, this real-world study demonstrates that assessing inflammation in patients with ASCVD and CKD stages 3–4 can help to identify a population with a high healthcare burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Primary Care and Public Health, School of Public Health, Imperial College London, 320 Reynolds Building, Charing Cross Campus, London, W6 8RP, UK.
- Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
- Novo Nordisk BV, Kon. Wilhelminaplein 2c, 1062 HK Amsterdam, Netherlands.
- Novo Nordisk A/S, Vandtårnsvej 108, 2860 Søborg, Denmark.
- LCP Health, Lane Clark & Peacock LLP, 95 Wigmore Street, London, W1U 1DQ, UK.
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, W2 1PG, UK.
ORCID-Profile: Kausik K Ray, Fotios Barkas, Eline L Huisman, Iram Faqir Muhammad, Hongye Ren, Simon Bertram Reuter, Andrew Thompson
Förderung
- Novo Nordisk A/S
Zitieren
APA
Ray, K. K., Barkas, F., Huisman, E. L., Mathisen, J., Muhammad, I. F., Ren, H., Reuter, S. B., Pearson-Stuttard, J., & Thompson, A. (2026). Association between elevated C-reactive protein and mortality, healthcare resource utilization and costs in patients with atherosclerotic cardiovascular disease and/or chronic kidney disease. European Heart Journal Open, 6(6). https://doi.org/10.1093/ehjopen/oeag177
Vancouver
Ray KK, Barkas F, Huisman EL, Mathisen J, Muhammad IF, Ren H, et al. Association between elevated C-reactive protein and mortality, healthcare resource utilization and costs in patients with atherosclerotic cardiovascular disease and/or chronic kidney disease. European Heart Journal Open. 2026;6(6). doi:10.1093/ehjopen/oeag177
BibTeX
@article{Ray2026,
author = {Ray, Kausik K and Barkas, Fotios and Huisman, Eline L and Mathisen, Jimmi and Muhammad, Iram Faqir and Ren, Hongye and Reuter, Simon Bertram and Pearson-Stuttard, Jonathan and Thompson, Andrew},
title = {Association between elevated C-reactive protein and mortality, healthcare resource utilization and costs in patients with atherosclerotic cardiovascular disease and/or chronic kidney disease},
journal = {European Heart Journal Open},
year = {2026},
volume = {6},
number = {6},
doi = {10.1093/ehjopen/oeag177}
}
EUVIMED